Ovarian cancer: can we reverse drug resistance?
Adv Exp Med Biol
.
2008:622:153-67.
doi: 10.1007/978-0-387-68969-2_13.
Authors
David S P Tan
1
,
Joo Ern Ang
,
Stan B Kaye
Affiliation
1
Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK.
PMID:
18546626
DOI:
10.1007/978-0-387-68969-2_13
No abstract available
Publication types
Review
MeSH terms
Animals
Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic
Drug Resistance, Neoplasm / physiology*
Female
Humans
Ovarian Neoplasms / drug therapy*
Substances
Antineoplastic Agents